Patents by Inventor Linda Cheng-Choo Tan

Linda Cheng-Choo Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180188271
    Abstract: The invention relates to a method for screening the binding properties of constituent peptides of MHC molecules by providing in solution MHC molecules or their constituent peptides for a set of MHC molecules including a plurality of subsets of MHC molecules, wherein the MHC molecules of each subset differ from MHC molecules of at least one other subset in at least one of the putative MHC binding peptide, an MHC alpha chain and an MHC beta chain, and loading said MHC molecules with an MHC binding peptide by (i) refolding of the MHC alpha chain and beta chain peptides in presence of said MHC binding peptide or (ii) by peptide exchange or loading with an unlabelled MHC binding peptide in the absence of any labelled MHC binding peptide, (b) taking of at least one sample from each subset, and (c) determining loading efficiency for the sample of step (b).
    Type: Application
    Filed: February 22, 2018
    Publication date: July 5, 2018
    Applicant: ProImmune Limited
    Inventors: Nikolai Franz Gregor SCHWABE, Linda Cheng-Choo TAN, Catherine Elizabeth GOUVEIA
  • Publication number: 20150293128
    Abstract: The invention relates to a method for screening the binding properties of constituent peptides of MHC molecules by providing in solution MHC molecules or their constituent peptides for a set of MHC molecules including a plurality of subsets of MHC molecules, wherein the MHC molecules of each subset differ from MHC molecules of at least one other subset in at least one of the putative MHC binding peptide, an MHC alpha chain and an MHC beta chain, and loading said MHC molecules with an MHC binding peptide by (i) refolding of the MHC alpha chain and beta chain peptides in presence of said MHC binding peptide or (ii) by peptide exchange or loading with an unlabelled MHC binding peptide in the absence of any labelled MHC binding peptide, (b) taking of at least one sample from each subset, and (c) determining loading efficiency for the sample of step (b).
    Type: Application
    Filed: June 26, 2015
    Publication date: October 15, 2015
    Applicant: Prolmmune Limited
    Inventors: Nikolai Franz Gregor SCHWABE, Linda Cheng-Choo Tan, Catherine Elizabeth Gouveia
  • Publication number: 20120245332
    Abstract: The present invention relates to an MHC binding polymer suitable for the oligomerisation of individual MHC monomers. The MHC binding polymer comprises a first segment and a second segment, wherein the first segment comprises a peptide capable of binding in a binding groove of an MHC molecule, and wherein the second segment comprises a linking segment and a recognition site for coupling the MHC binding polymer with a specific partner. The linking segment is a polymer with a length of at least 10 Angstrom in its native conformation. Further it relates to an MHC oligomer containing such MHC binding polymers. Individual functional MHC complex monomers are oligomerised via their peptides bound in the peptide binding groove of the complex. Moreover, it relates to a method of making such MHC binding polymer and oligomer and various methods using the same.
    Type: Application
    Filed: March 15, 2012
    Publication date: September 27, 2012
    Inventors: Nikolai Franz Gregor SCHWABE, Linda Cheng-Choo TAN, Catherine Elizabeth GOUVEIA, Joanna COX
  • Publication number: 20120214185
    Abstract: The invention relates to a method for screening the binding properties of constituent peptides of MHC molecules by providing in solution MHC molecules or their constituent peptides for a set of MHC molecules including a plurality of subsets of MHC molecules, wherein the MHC molecules of each subset differ from MHC molecules of at least one other subset in at least one of the putative MHC binding peptide, an MHC alpha chain and an MHC beta chain, and loading said MHC molecules with an MHC binding peptide by (i) refolding of the MHC alpha chain and beta chain peptides in presence of said MHC binding peptide or (ii) by peptide exchange or loading with an unlabelled MHC binding peptide in the absence of any labelled MHC binding peptide, (b) taking of at least one sample from each subset, and (c) determining loading efficiency for the sample of step (b).
    Type: Application
    Filed: January 17, 2012
    Publication date: August 23, 2012
    Inventors: NIKOLAI FRANZ GREGOR SCHWABE, Linda Cheng-Choo Tan, Catherine Elizabeth Gouveia
  • Publication number: 20100190927
    Abstract: The present invention relates to an MHC binding polymer suitable for the oligomerisation of individual MHC monomers. The MHC binding polymer comprises a first segment and a second segment, wherein the first segment comprises a peptide capable of binding in a binding groove of an MHC molecule, and wherein the second segment comprises a linking segment and a recognition site for coupling the MHC binding polymer with a specific partner. The linking segment is a polymer with a length of at least 10 Angstrom in its native conformation. Further it relates to an MHC oligomer containing such MHC binding polymers. Individual functional MHC complex monomers are oligomerised via their peptides bound in the peptide binding groove of the complex. Moreover, it relates to a method of making such MHC binding polymer and oligomer and various methods using the same.
    Type: Application
    Filed: August 1, 2007
    Publication date: July 29, 2010
    Applicant: PROIMMUNE LIMITED
    Inventors: Nikolai Franz Gregor Schwabe, Linda Cheng-Choo Tan, Catherine Elizabeth Gouveia
  • Publication number: 20090137472
    Abstract: The invention concerns a oligomeric MHC complex comprising at least two chimeric proteins, said chimeric proteins comprising a first section derived from an MHC peptide chain or a functional part thereof and a second section comprising an oligomerising domain derived from an oligomer-forming coiled-coil protein, wherein formation of the oligomeric MHC complex occurs by oligomerisation at the oligomerising domain of the chimeric proteins, and wherein at least two of the first sections are derived from the same MHC peptide chain. The invention also concerns a chimeric protein comprising a first section derived from an MHC peptide chain or a functional part thereof and a second section comprising an oligomerising domain derived from an oligomer-forming coiled-coil protein.
    Type: Application
    Filed: October 23, 2008
    Publication date: May 28, 2009
    Inventors: Nikolai Franz Gregor Schwabe, Linda Cheng-Choo Tan, Catherine Elizabeth Napper, Jeremy William Fry, Susan Pang, Rachel Kate Spooner
  • Publication number: 20080206789
    Abstract: The invention relates to a method for screening the binding properties of constituent peptides of MHC molecules by providing in solution MHC molecules or their constituent peptides for a set of MHC molecules including a plurality of subsets of MHC molecules, wherein the MHC molecules of each subset differ from MHC molecules of at least one other subset in at least one of the putative MHC binding peptide, an MHC alpha chain and an MHC beta chain, and loading said MHC molecules with an MHC binding peptide by (i) refolding of the MHC alpha chain and beta chain peptides in presence of said MHC binding peptide or (ii) by peptide exchange or loading with an unlabelled MHC binding peptide in the absence of any labelled MHC binding peptide, (b) taking of at least one sample from each subset, and (c) determining loading efficiency for the sample of step (b).
    Type: Application
    Filed: September 15, 2006
    Publication date: August 28, 2008
    Inventors: Nikolai Franz Gregor Schwabe, Linda Cheng-Choo Tan, Catherine Elizabeth Gouveia
  • Publication number: 20040209295
    Abstract: The invention concerns a oligomeric MHC complex comprising at least two chimeric proteins, said chimeric proteins comprising a first section derived from an MHC peptide chain or a functional part thereof and a second section comprising an oligomerising domain derived from an oligomer-forming coiled-coil protein, wherein formation of the oligomeric MHC complex occurs by oligomerisation at the oligomerising domain of the chimeric proteins, and wherein at least two of the first sections are derived from the same MHC peptide chain. The invention also concerns a chimeric protein comprising a first section derived from an MHC peptide chain or a functional part thereof and a second section comprising an oligomerising domain derived from an oligomer-forming coiled-coil protein.
    Type: Application
    Filed: February 2, 2004
    Publication date: October 21, 2004
    Inventors: Nikolai Franz Gregor Schwabe, Linda Cheng-Choo Tan, Catherine Elizabeth Napper, Jeremy William Fry, Susan Pang, Rachel Kate Spooner